Albumin and Albumin fusion proteins
Human Serum Albumin has a vast array of applications within the biopharmaceutical industry. In particular it acts as a fusion partner to extend the half-life of a protein drug whilst maintaining its activity.
ProMeticBioSciences Ltd., based in the UK, has developed a range of highly stable, robust, non-toxic affinity matrices. The high affinity matrices support the variety of recombinant albumin and albumin fusion proteins and provide high binding capacity, recovery and purity: